I agree that this site is using cookies. You can find further informations here.
X
Gazzard, Brian
301  results:
Search for persons X
?
1

Improving the evidence for indicator condition guided HIV t..:

Raben, Dorthe ; Sullivan, Ann Kathleen ; Mocroft, Amanda...
PLOS ONE.  14 (2019)  8 - p. e0220108 , 2019
Link: https://doi.org/10.1371/..
 
?
2

Pharmacological impact of antiretroviral therapy on platele..:

Taylor, Kirk A. ; Smyth, Erica ; Rauzi, Francesca...
British Journal of Pharmacology.  176 (2019)  7 - p. 879-889 , 2019
Link: https://doi.org/10.1111/..
 
?
3

Immunodeficiency and the gut:

Gazzard, Brian
Medicine.  47 (2019)  6 - p. 347-349 , 2019
Link: https://doi.org/10.1016/..
 
?
4

Chronic Kidney Disease Risk in African and Caribbean Popula..:

Jose, Sophie ; Hamzah, Lisa ; Jones, Rachael...
The Journal of Infectious Diseases.  218 (2018)  11 - p. 1767-1772 , 2018
Link: https://doi.org/10.1093/..
 
?
5

Durability of viral suppression with first-line antiretrovi..:

O'Connor, Jemma ; Smith, Colette ; Lampe, Fiona C...
The Lancet HIV.  4 (2017)  7 - p. e295-e302 , 2017
Link: https://doi.org/10.1016/..
 
?
6

Changes in Cardiovascular Disease Risk Factors With Immedia..:

Baker, Jason V. ; Sharma, Shweta ; Achhra, Amit C....
Journal of the American Heart Association.  6 (2017)  5 - p. , 2017
Link: https://doi.org/10.1161/..
 
?
7

First-in-Human Evaluation of the Safety and Immunogenicity ..:

Nyombayire, Julien ; Anzala, Omu ; Gazzard, Brian...
The Journal of Infectious Diseases.  215 (2017)  1 - p. 95-104 , 2017
Link: http://www.jstor.org/sta..
 
?
8

Pre-exposure prophylaxis to prevent the acquisition of HIV-..:

McCormack, Sheena ; Dunn, David T ; Desai, Monica...
The Lancet.  387 (2016)  10013 - p. 53-60 , 2016
Link: https://doi.org/10.1016/..
 
?
9

First-in-Human Evaluation of the Safety and Immunogenicity ..:

Nyombayire, Julien ; Anzala, Omu ; Gazzard, Brian...
Journal of Infectious Diseases.  215 (2016)  1 - p. 95-104 , 2016
Link: https://doi.org/10.1093/..
 
?
10

Immunodeficiency and the gut:

Gazzard, Brian
Medicine.  43 (2015)  5 - p. 259-261 , 2015
Link: https://doi.org/10.1016/..
 
?
11

30 years of HIV: what have we learned?:

Gazzard, Brian
Journal of the International AIDS Society.  17 (2014)  4S3 - p. , 2014
Link: https://doi.org/10.7448/..
 
?
12

Long‐term efficacy and safety of E/C/F/TDF vs EFV/FTC/TDF a..:

Gazzard, Brian ; Marie Girard, Pierre ; Di Perri, Giovanni...
Journal of the International AIDS Society.  17 (2014)  4S3 - p. , 2014
Link: https://doi.org/10.7448/..
 
?
13

Patient preferences for characteristics of antiretroviral t..:

Gazzard, Brian ; Ali, Shehzad ; Muhlbacher, Axel...
Journal of the International AIDS Society.  17 (2014)  4S3 - p. , 2014
Link: https://doi.org/10.7448/..
 
?
14

Feasibility and Effectiveness of Indicator Condition-Guided..:

Sullivan, Ann K. ; Raben, Dorthe ; Reekie, Joanne...
PLoS ONE.  8 (2013)  1 - p. e52845 , 2013
Link: https://doi.org/10.1371/..
 
?
15

Early and non-reversible decrease of CD161++/mucosal associ..:

Cosgrove, Cormac ; Ussher, James E. ; Rauch, Andri...
Journal of Infection.  67 (2013)  4 - p. 342-343 , 2013
Link: https://doi.org/10.1016/..
 
1-15